NEOGENOMICS INC (NEO)

US64049M2098 - Common Stock

15.3  +0.58 (+3.94%)

After market: 15.3 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2030
Revenue
YoY % growth
484.3M
8.98%		509.7M
5.24%		591.643M
16.08%		661.11M
11.74%
EBITDA
YoY % growth
-49.75M
-308.86%		-83.67M
-68.18%		-24.065M
71.24%		23.213M
196.46%		N/A
EBIT
YoY % growth
-103.1M
-766.39%		-153.1M
-48.50%		-96.648M
36.87%		-76.421M
20.93%
Operating Margin
-21.29%-30.04%-16.34%-11.56%
EPS
YoY % growth
-0.27
-292.86%		-0.56
-107.41%		-0.11
80.36%		-0.01
92.49%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.01
72.45%
Revenue
Q2Q % growth		164.28M
11.83%
EBITDA
Q2Q % growth		4.549M
EBIT
Q2Q % growth		-20.084M
25.06%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.02
77.78%		-0.050.0359.66%
Q4 2023
Q2Q % growth		 0.03
150.00%		-0.030.06219.19%
Q3 2023
Q2Q % growth		 0.00
100.00%		-0.080.08100.00%
Q2 2023
Q2Q % growth		 -0.05
68.75%		-0.110.0656.40%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 156.24M
13.88%		151.39M4.85M3.20%
Q4 2023
Q2Q % growth		 155.552M
12.15%		154.06M1.492M0.97%
Q3 2023
Q2Q % growth		 152M
18.01%		143.06M8.94M6.25%
Q2 2023
Q2Q % growth		 146.9M
17.43%		138.8M8.1M5.84%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 50.33% -181.8% 90.5%
Revenue0% 2.53% -0.02% 3.5%